Does rituximab aggravate pre-existing hypogammaglobulinaemia?DIWAKAR, Lavanya; GORRIE, Sheryl; RICHTER, Alex et al.Journal of clinical pathology. 2010, Vol 63, Num 3, pp 275-277, issn 0021-9746, 3 p.Article

Update on rituximabEISENBERG, R.Annals of the rheumatic diseases. 2005, Vol 64, pp iv55-iv57, issn 0003-4967, SUP4Conference Paper

Development of novel humanized anti-CD20 antibodies based on affinity constant and epitopeUCHIYAMA, Susumu; SUZUKI, Yasuhiko; FUKUI, Kiichi et al.Cancer science. 2010, Vol 101, Num 1, pp 201-209, issn 1347-9032, 9 p.Article

Mechanism of impaired immunologic response to bacterial antigens in burn wounds in childrenANDRZEJEWSKA, E; NIEWIADOMSKA, H; NAWROT, E et al.Pediatric surgery international. 2000, Vol 16, Num 1-2, pp 85-88, issn 0179-0358Article

Rituximab : Applications in dermatologyFATOURECHI, Mitra M; EL-AZHARY, Rokea A; GIBSON, Lawrence E et al.International journal of dermatology. 2006, Vol 45, Num 10, pp 1143-1155, issn 0011-9059, 13 p.Article

Lineage determination of CD20- B-cell neoplasms : An immunohistochemical studyCHU, Peiguo G; LOERA, Sofia; QIN HUANG et al.American journal of clinical pathology. 2006, Vol 126, Num 4, pp 534-544, issn 0002-9173, 11 p.Article

CD20-Targeted Therapy: The Next Generation of AntibodiesVAN MEERTEN, Tom; HAGENBEEK, Anton.Seminars in hematology. 2010, Vol 47, Num 2, pp 199-210, issn 0037-1963, 12 p.Article

Place des anticorps monoclonaux (anti-CD52, anti-CD20) dans la leucémie lymphoïde chroniqueDIVINE, Marine.Hématologie (Montrouge). 2006, Vol 12, pp 35-38, issn 1264-7527, 4 p., NS6Article

Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disordersLEVESQUE, M. C.Clinical and experimental immunology (Print). 2009, Vol 157, Num 2, pp 198-208, issn 0009-9104, 11 p.Article

Utilisation du rituximab dans les maladies auto-immunes en pédiatrieRevue du rhumatisme (Ed. française). 2013, Vol 80, pp 23-31, issn 1169-8330, 9 p., HS1Article

Rituximab: Mechanism of ActionWEINER, George J.Seminars in hematology. 2010, Vol 47, Num 2, pp 115-123, issn 0037-1963, 9 p.Article

Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 AbGOPAL, Ajay K; PRESS, Oliver W; WILBUR, Shani M et al.Blood. 2008, Vol 112, Num 3, pp 830-835, issn 0006-4971, 6 p.Article

A case of reversible posterior leucoencephalopathy syndrome after rituximab infusionMAVRAGANI, C. P; VLACHOYIANNOPOULOS, P. G; KOSMAS, N et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 11, pp 1450-1451, issn 1462-0324, 2 p.Article

Recurrent miscarriage is associated with increased numbers of CD5/20 positive lymphocytes and an increased incidence of thyroid antibodiesROBERTS, J; JENKINS, C; WILSON, R et al.European journal of endocrinology. 1996, Vol 134, Num 1, pp 84-86, issn 0804-4643Article

Implication du cytosquelette dans l'expression et le clivage du récepteur de basse affinité pour les IgE (CD23) dans les lymphocytes B humains = Implication of the cytoskeleton in the expression and cleavage of the low affinity IgE-receptor (CD23) in human B lymphocytesDi Berardino, Wilma; Cousin, J.-L.1996, 78 p.Thesis

Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domainsEINFELD, D. A; BROWN, J. P; VALENTINE, M. A et al.EMBO journal (Print). 1988, Vol 7, Num 3, pp 711-717, issn 0261-4189Article

A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignanciesSEHN, Laurie H; ASSOULINE, Sarit E; STEWART, Douglas A et al.Blood. 2012, Vol 119, Num 22, pp 5118-5125, issn 0006-4971, 8 p.Article

Detection of a monoclonal antibody therapy (ofatumumab) by serum protein and immunofixation electrophoresisGENZEN, Jonathan R; KAWAGUCHI, Kathy R; FURMAN, Richard R et al.British journal of haematology. 2011, Vol 155, Num 1, pp 123-125, issn 0007-1048, 3 p.Article

Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized TherapiesCARTRON, Guillaume; ULRICH TRAPPE, Ralf; SOLAL-CELIGNY, Philippe et al.Clinical cancer research (Print). 2011, Vol 17, Num 1, pp 19-30, issn 1078-0432, 12 p.Article

CD20 expression in natural killer T cell lymphomaGILL, Harinder S; LAU, Wing-Hung; CHAN, Alexander C. L et al.Histopathology. 2010, Vol 57, Num 1, pp 157-159, issn 0309-0167, 3 p.Article

Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell MalignanciesCHESON, Bruce D.Journal of clinical oncology. 2010, Vol 28, Num 21, pp 3525-3530, issn 0732-183X, 6 p.Article

Rituximab-induced acute severe thrombocytopeniaPARAJULI, Ritesh; HIRE, Ervin; SHAH, Binay K et al.British journal of haematology. 2010, Vol 149, Num 6, issn 0007-1048, p. 804Article

Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker resultsKAVANAUGH, A; ROSENGREN, S; LEE, S. J et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 3, pp 402-408, issn 0003-4967, 7 p.Article

Successful treatment with rituximab in a patient with an acquired factor V inhibitorLEBRUN, Agnes; LEROY-MATHERON, Catherine; ARLET, Jean-Benoit et al.American journal of hematology. 2008, Vol 83, Num 2, pp 163-164, issn 0361-8609, 2 p.Article

Progress in immunotherapy RituximabEL-HABBASH, Manal M; ALWINDI, Abukris M.Saudi medical journal. 2007, Vol 28, Num 11, pp 1635-1644, issn 0379-5284, 10 p.Article